SP
GPCR icon

SmartHarvest Portfolios’s Structure Therapeutics GPCR Stock Holding History

SmartHarvest Portfolios’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
9,928
+872
+10% +$38.6K 0.17% 121
2026
Q1 		$436K Hold
9,056
– – 0.18% 117
2025
Q4 		$630K Buy
+9,056
New +$370K 0.22% 90

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SmartHarvest Portfolios's GPCR Position: Q2 2026 in Review

SmartHarvest Portfolios increased its Structure Therapeutics (GPCR) stake by 9.6% in Q2 2026, buying an estimated $38.6K and bringing the position to 9,928 shares worth $533K. The position accounts for 0.17% of the portfolio, ranked #121.

SmartHarvest Portfolios first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $630K in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • SmartHarvest Portfolios held 9,928 shares of Structure Therapeutics worth $533K as of Q2 2026.
  • SmartHarvest Portfolios bought 872 Structure Therapeutics shares in Q2 2026, an estimated $38.6K.
  • Structure Therapeutics made up 0.17% of SmartHarvest Portfolios's portfolio in Q2 2026, its #121 holding.
  • SmartHarvest Portfolios first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • SmartHarvest Portfolios's Structure Therapeutics position peaked at $630K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on SmartHarvest Portfolios's 13F filing for Q2 2026, filed 4 Aug 2026.